Endocrinology Vol. 139, No. 6 2857-2862
Copyright © 1998 by The Endocrine Society
Endogenous Opioid Peptides Contribute to Suckling-Induced Prolactin Release by Suppressing Tyrosine Hydroxylase Activity and Messenger Ribonucleic Acid Levels in Tuberoinfundibular Dopaminergic Neurons1
Lydia A. Arbogast and
James L. Voogt
Department of Physiology, University of Kansas Medical Center,
Kansas City, Kansas 66160-7401
Address all correspondence and requests for reprints to: Dr. Lydia A. Arbogast, Department of Physiology, School of Medicine, Southern Illinois University at Carbondale, Carbondale, Illinois 62901-6512. E-mail: larbogast{at}som.siu.edu
 |
Abstract
|
|---|
The endogenous opioid peptides have been implicated in the control of
the suckling-induced PRL rise during lactation. This study examined the
role of the endogenous opioid peptides in suppressing
tuberoinfundibular dopaminergic neuronal activity during lactation. In
the first experiment, lactating rats were constantly exposed to pups.
Naloxone (NAL; 60 mg/kg·h; iv), an opioid receptor antagonist, or
saline was infused for 12 h. Blood was collected before and at 2-h
intervals during the infusion. NAL suppressed circulating PRL levels to
less than 36% of control values at 4, 6, 8, and 12 h after the
onset of the infusion. Tyrosine hydroxylase (TH) activity in the
stalk-median eminence and TH messenger RNA signal levels in the arcuate
nucleus were determined at the end of the NAL infusion. TH activity and
TH messenger RNA signal levels were increased 2.5- and 2.7-fold,
respectively, after the 12-h NAL infusion. Even though the time spent
with their pups was similar between the two groups, the pups in the
NAL-treated group failed to gain weight during the 12-h NAL infusion
period, whereas the control litters (8 pups) gained 5 g. In a
second experiment, pups were removed from the dams before the 12-h NAL
infusion and were returned after 11 h. Blood was collected before
the infusion, at 3-h intervals during the pup separation period, and at
15-min intervals after reunion with the pups. Plasma PRL in control and
NAL-treated rats was low (115 ng/ml) and similar during the
separation period. The suckling-induced PRL surge in NAL-treated rats
was markedly attenuated to 925% of control levels (350650 ng/ml).
After a 1-h suckling episode, TH activity in the stalk-median eminence
of NAL-treated rats was 4.5-fold greater than controls. Litter weight
gains were significantly less in NAL-treated rats during the 1-h
suckling episode. These data indicate that the endogenous opioid
peptides are an integral component for increasing PRL release in
response to suckling and they act to decrease tuberoinfundibular
dopaminergic neuronal activity during lactation, in part, by
suppressing TH gene expression.
 |
Introduction
|
|---|
THE SUCKLING stimulus from the young is the
most powerful signal to increase PRL secretion in mammalian species.
The control of PRL secretion during lactation involves increased input
from PRL releasing factor(s) (1, 2, 3) and decreased tuberoinfundibular
dopaminergic (TIDA) neuronal activity (4, 5, 6, 7, 8, 9). The effect of suckling on
dopaminergic activity is illustrated most dramatically by the large
increase in neuronal activity seen after separation from the pups. The
changes in neuronal activity after pup removal are manifested by
increased dopamine secretion in hypophysial portal blood (4), increased
dihydroxyphenylalanine (DOPA) accumulation in the median eminence (7, 9), increased tyrosine hydroxylase (TH) messenger RNA (mRNA) levels in
the arcuate nucleus (8, 9), and increased Fos-related antigen
expression in the TIDA neurons (10). However, the complex neuronal
pathways involved in translating the suckling stimulus to increased PRL
secretion and the interactions between these factors and the TIDA
neurons are not completely understood.
The endogenous opioid peptides have also been implicated in the
suckling-induced PRL rise. The acute suckling-induced PRL rise is
blocked by naloxone (NAL) (11, 12), as well as specific µ and
opioid receptor antagonists (12). Although it is not known which of the
endogenous opioid peptides contribute to the suckling-induced PRL
release, ß-endorphin (11, 13), as well as specific µ-selective
opioid peptides (14), can acutely increase PRL release in postpartum
rats. NAL (11), as well as µ,
, and
(13) receptor antagonists
can block ß-endorphin-induced PRL release in postpartum rats.
Although it is not clear which of the endogenous opioid systems
contribute to the elevated PRL levels in response to the suckling
stimulus, there is evidence that opioid gene expression in hypothalamic
areas is different during lactation than other endocrine states in
female rats. The POMC cellular mRNA signal levels (15) or number of
POMC mRNA-containing cells (16) in the arcuate nucleus and periarcuate
area were less in lactating rats than in diestrous rats. However, few
of the TIDA perikarya receive contacts from ß-endorphin terminals
(17, 18), although one cannot rule out interactions at the level of the
median eminence. In contrast, proenkephalin mRNA levels in the arcuate
nucleus were higher during lactation, compared with diestrous females
(19). The induction of enkephalin immunoreactivity in the TIDA neurons
during lactation (20) furnishes a way for enkephalin to act as an
autocrine regulator of TIDA neurons during lactation. Prodynorphin mRNA
levels in the paraventricular nucleus were also higher in lactating
than in diestrous rats (21). Indeed, about 70% of the TIDA neurons
have contacts with dynorphin terminals (17), and immunoneutralization
of dynorphin results in increased TIDA neuronal activity in male rats
(22).
It seems that the endogenous opioid peptides exert their action at the
hypothalamic level to alter PRL secretion (23, 24, 25). Although a
nondopaminergic mechanism(s) may also be involved in the opiate
stimulation of PRL release (26, 27), a number of studies indicate that
the endogenous opioid peptides interact with the TIDA neurons. The
endogenous opioid peptides (28, 29, 30, 31, 32), morphine (30, 31, 33, 34) and
specific agonists (35, 36) suppress TIDA neuronal activity. This opioid
peptide-dopamine interaction seems to be physiologically important
during the nocturnal PRL surge in pregnant rats (37). Recently,
Callahan et al. (38) reported that µ-, but not
-opioid
receptor antagonists increase DOPA accumulation in the median eminence
of both pup-deprived and pup-suckled dams after a 45 h separation
period. The objective of this study was to evaluate whether the opioid
effect on dopaminergic neurons is physiologically important in the
regulation of PRL release during lactation.
 |
Materials and Methods
|
|---|
Animals
Female Sprague-Dawley rats (225250 g) were obtained from Sasco
(Omaha, NE). Rats were housed under controlled temperature (22 C) and
lighting conditions (lights on 06001800 h) and supplied with food and
water ad libitum. All procedures were approved by the Kansas
University Medical Center animal care and use committee. The estrous
cycles of female rats were followed by daily vaginal lavage. Each
female was placed with a single male on the day of proestrus for mating
purposes. Pregnant rats were housed individually after day 16 of
gestation. The litter size was adjusted to eight pups per dam on
postpartum day 2 (parturition day = day 1). The dams were
implanted with a jugular vein cannula under ether anesthesia on day 5
of lactation and allowed to recover for 2 days before the
experiments.
Exp 1: constant suckling stimulus
The lactating rats with litters were placed in the experimental
cages on day 6 of lactation. An extension tubing was connected to the
cannula between 08000900 h on day 7 of lactation to allow for blood
sampling without disturbing the rats. The litters were weighed and
returned to the dams. An infusion of NAL (60 mg/kg·h; iv) or
heparinized saline (20 U/ml heparin; 300 µl/h; iv) was initiated at
0900 h, immediately after an initial (0 min) blood sample. The
concentration of NAL was adjusted to individual body weights so that
the vol of infusion was 300 µl/h. To evaluate the contribution of
behavioral changes, the rats were observed at 2-h intervals and scored
with a plus (lactating dam with pups in nest) or minus (dam away from
pups). In addition, the attachment of pups to the nipples was noted.
After observation, blood samples (350 µl) were collected from the
jugular vein cannula at 2-h intervals for a 12-h period. After each
sample, the extension tubing and cannula were filled with a
predetermined volume of either NAL or heparinized saline to completely
fill all tubing. The extension tubing was immediately reconnected to
the pump so that the infusion would continue uninterrupted. The
interruption of the infusion caused by sampling was less than 2 min
every 2 h. For in situ hybridization studies, the rats
were rapidly decapitated at 2100 h after the 12-h infusion period;
the brains were collected and frozen immediately in Histofreeze 2000
(Fisher Scientific, St Louis, MO) at -70 C. In experiments to evaluate
TH activity, the rats were injected with m-hydroxybenzylhydrazine
dihydrochloride (NSD 1015; 25 mg free base/kg; iv), an
L-aromatic amino acid decarboxylase inhibitor, after the
12-h blood sample and rapidly decapitated after an additional 15 min.
The NAL/vehicle infusion was continued after the NSD 1015 injection.
The stalk-median eminence (SME) was dissected with fine scissors,
frozen immediately on dry ice, and stored at -20 C until analyzed for
catecholamine content. In both groups, the litters were weighed at the
completion of the experiment.
Exp 2: acute sucking stimulus
An extension tubing was connected to the jugular vein cannula at
the start of the experiment and a 0 h blood sample collected. The
pups were then removed from the dams and weighed. NAL (60 mg/kg·h;
iv) or heparinized saline infusion was initiated. Blood samples were
collected at 3, 6, and 9 h during the infusion period. After
11 h of infusion, the litters were weighed again and returned to
the dams immediately after a 0 min blood sample was collected. Blood
was collected at 15, 30, 45, and 60 min after the onset of the suckling
stimulus (4 pups attached to nipples). After the 60-min blood sample,
NSD 1015 (25 mg/kg; iv) was injected. The lactating rats were rapidly
decapitated after 15 min, the SME dissected, and DOPA accumulation
determined. The litters were weighed at the end of the 1-h suckling
episode.
Determination of DOPA accumulation
The SME was homogenized in 120 µl of 0.1 N perchloric acid and
centrifuged at 10,000 x g for 2 min. The content of
DOPA in the SME was determined by HPLC with electrochemical detection,
as described previously (39). The pellet was solubilized in 0.5 N
sodium hydroxide and analyzed for protein content by the method of
Bradford (40).
In situ hybridization for TH mRNA
Coronal sections (15 µM) were cut through the
arcuate nucleus and thaw mounted on Superfrost Plus microscope slides
(Fisher Scientific). Brain sections were fixed in 4% paraformaldehyde
and subjected to an in situ hybridization procedure, as
described previously (39). After prehybridization steps, the brain
sections were hybridized overnight at 45 C with 2 x
106 dpm of a specific antisense 35S-labeled
cRNA probe for TH with a specific activity of 5 x 108
dpm/µg. The probe was synthesized using SP6 RNA polymerase from a
1.1-kb BamHI/EcoRI insert subcloned into a pSP65
vector. After ribonuclease treatment and a series of posthybridization
washes that increased in stringency, the slides were dipped in Ilford
Emulsion (K-5), diluted 0.25 g/ml water. The autoradiographs were
exposed for 4 weeks, developed by standard photographic methods, and
poststained lightly with hematoxylin.
The anatomical locations of the tissue sections were determined using
the rat brain atlas of Paxinos and Watson (41). The rostral border was
-2.5 mm, and the caudal border was -3.1 mm from the bregma.
Approximately 18 cells/tissue section (i.e. 300350
cells/rat), selected from all areas of the arcuate nucleus, were
analyzed. TH mRNA-containing cells were identified, under darkfield
optics, as a cluster of reduced silver grains with an identifiable cell
nucleus. The number of grains in individual mRNA-containing cells was
measured under x 400 darkfield illumination by a computerized
image-processing system (Georgia Instruments, Roswell, GA).
PRL determinations
The blood was centrifuged at 10,000 x g for 5
min, and plasma PRL levels were determined using the rat PRL RIA kit
provided by NIDDK. PRL RP-3 was used as the reference preparation and
[125 I]PRL (New England Nuclear, Boston, MA) as the
radiolabeled antigen. The limit of sensitivity for the assay was 1
ng/ml. The intra- and interassay coefficients of variation were 12.1%
and 9.1%, respectively.
Statistical analysis
Results are expressed as the mean ± SE. The n
for all groups refers to the number of experimental animals. When two
groups were compared, the data were analyzed by Students t
test (42). For circulating PRL levels, the data were analyzed by ANOVA
for repeated measures, and multiple comparisons were made with
Fishers least-significant procedures (42, 43).
 |
Results
|
|---|
Effect of NAL on circulating PRL levels
In the first experiment, the lactating rats were constantly
exposed to their pups for the entire 12-h experimental period, so that
the suckling stimulus would be maintained for an extended period of
time. Fig. 1
shows circulating PRL
concentrations at 2-h intervals in control and NAL-treated rats. An
initial fall in circulating PRL levels during the first 2 h was
observed in both groups, likely because of manipulations to attach the
extension tubing and weighing the pups. In control rats, PRL levels
were consistently elevated to approximately 200 ng/ml during 412 h of
saline infusion. However, plasma PRL levels in the NAL-treated rats
were markedly lower (P < 0.05) than control
values.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 1. Circulating PRL levels in lactating rats, which
were constantly exposed to pups, during saline (control) or NAL (60
mg/kg·h; iv) infusion. Plasma PRL levels in the NAL-treated rats were
markedly lower than control values at 412 h during the infusion
period. Each value is a mean ± SE of determinations
from 17 (control) or 14 (NAL) rats. *, Values significantly
(P < 0.05) different from the respective control
values.
|
|
Tuberoinfundibular dopaminergic neuronal function
A 12-h period was selected for the NAL infusion, because this is
the time required for near maximal increase in TH mRNA levels after pup
removal (8). In pup-exposed lactating rats, TH activity in the SME was
2.5-fold greater (P < 0.05) after 12 h of NAL
infusion than after saline control infusion (Fig. 2
, left panel). Similarly, TH
mRNA signal levels in the arcuate nucleus were increased
(P < 0.05) 2.7-fold after 12 h of NAL infusion
(Fig. 2
, middle panel; Fig. 3
). In contrast, TH mRNA signal levels in
the medial zona incerta were similar in control and NAL-treated rats
(Fig. 2
, right panel).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2. TH activity in the SME (left panel)
and TH mRNA signal levels in the arcuate nucleus (middle
panel) and medial zona incerta (right panel) of
pup-exposed lactating rats, after 12 h saline (control) or NAL (60
mg/kg·h; iv) infusion. TH activity in the SME and TH mRNA signal
levels in the arcuate nucleus are increased after NAL infusion. Each
value is a mean ± SE of determinations from eight to
nine rats (TH activity) or six rats (TH mRNA levels). *, Significantly
(P < 0.05) different from the respective control
values.
|
|

View larger version (106K):
[in this window]
[in a new window]
|
Figure 3. Darkfield photomicrographs show coronal sections
through the arcuate nucleus at the level of the midmedian eminence
after 12-h saline (control; left panel) or NAL (60
mg/kg·h; iv; right panel) infusion. Note the presence
of cell bodies in the arcuate nucleus with a dense accumulation of
silver grains. The brightness of the TH mRNA-containing cells is
increased after NAL infusion.
|
|
Litter weight changes and behavioral observations
To assess the physiological consequences of NAL treatment on the
pups, the litters (eight pups/litter) were weighed before starting the
12-h infusion and after the conclusion of the infusion. Control litters
gained about 5 g/8 pups during the 12 h of suckling (Fig. 4
). In contrast, the litters from the
NAL-treated rats did not gain weight during the 12-h period. For
comparison, the litter weight loss associated with 12 h of
separation from normal dams was determined. The separated litters lost
significantly (P < 0.05) more weight (approximately 2
g/8 pups) than litters from NAL-treated dams during the 12-h
period.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 4. Litter (eight pups) weight change during the 12-h
period for lactating rats, which were constantly exposed to their pups,
during saline (control) or NAL (60 mg/kg·h; iv) infusion. Litters
from control rats gained weight during 12 h of suckling, whereas
litters from NAL-treated rats did not gain weight. For comparison, the
weight loss associated with 12 h of separation from normal dams is
shown in the open bar. Each value is a mean ±
SE of determinations from 1417 rats. *, Significantly
(P < 0.05) different from control values.
|
|
The percent of time the dams spent in the nest with the pups was
estimated by observations at 2-h intervals during the 12-h infusion of
NAL or saline. Control dams spent 73.4 ± 4.5% time, and
NAL-treated dams spent 62.0 ± 7.2% time with the pups. Thus, the
NAL infusion did not alter the percent time the dams spent in the nest.
Pups were attached to the nipples when the dams were with the nest
similarly in both groups of rats.
Acute suckling induced PRL rise and TH activity
A separate experiment evaluated the effect of NAL on the acute
suckling-induced PRL rise. The pups were removed at the beginning of
the experiment and returned to the dams after an 11-h separation
period. At the time the pups were removed, PRL levels were high (380
ng/ml) in the two groups of rats before the onset of treatment (Fig. 5
). Within 3 h after pup removal,
PRL levels were comparably less than 2 ng/ml in both the control and
NAL-treated rats and remained low and similar for the 11-h separation
period. In the control rats, PRL levels were markedly elevated, to 650
ng/ml, within 15 min after the pups were returned. In sharp contrast,
PRL levels were only 56 ng/ml in the NAL-treated rats after the pups
were returned. The suckling-induced PRL levels remained elevated to
350400 ng/ml for 60 min in the control rats, whereas the
suckling-induced PRL rise was markedly suppressed, to less than 100
ng/ml at 1560 min after the onset of suckling in the NAL-treated
rats.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 5. Circulating PRL levels in lactating rats from
which pups were removed during the initial 11 h of saline
(control) or NAL (60 mg/kg·h; iv) infusion and pups were returned
during the final 1 h of treatment. During the 11-h period of pup
separation, circulating PRL values were similar in control and
NAL-treated rats. After return of the pups, the suckling-induced PRL
surge was markedly suppressed at 1560 min after the onset of
suckling. Each value is a mean ± SE of determinations
from eight rats. *, Significantly (P < 0.05)
different from the respective control values.
|
|
TH activity in the SME was evaluated in these same groups of rats after
the 60-min suckling stimulus. The suckling stimulus was continued
during the 15-min period of DOPA accumulation after NSD 1015 injection
iv to undisturbed dams. TH activity in the SME of lactating rats was
increased (P < 0.05) 4.5-fold in the NAL-treated group
after a 1-h suckling episode at the end of a 12-h NAL or saline
(control) infusion period (Fig. 6
).

View larger version (21K):
[in this window]
[in a new window]
|
Figure 6. TH activity in the SME of lactating rats after a
1-h suckling episode at the end of a 12-h saline (control) or NAL (60
mg/kg·h; iv) infusion. TH activity was increased in NAL-treated rats.
Each value is a mean ± SE of determinations from
eight to nine rats. *, Significantly (P < 0.05)
different from control values.
|
|
 |
Discussion
|
|---|
We are reporting that an endogenous opioid peptide(s) decreases
TIDA neuronal activity during lactation and thus contributes to the
elevated PRL levels essential for normal lactation. The data in this
study indicate that many aspects of the TIDA neurons are attenuated by
the opioidergic input, including TH gene expression at the molecular
level. Conclusions of an endogenous opioid peptide(s) involvement in
these processes stem from studies using NAL, an opioid receptor
antagonist. Infusion of NAL caused a marked increase in TH activity in
the SME and TH mRNA in the arcuate nucleus. This augmented TIDA
neuronal activity was associated with suppression of both the high PRL
levels associated with a constant suckling stimulus and the acute
suckling-induced PRL rise after pup separation. Moreover, the
NAL-induced suppression of PRL secretion had physiological
consequences, in terms of reduced pup weight gain during suckling.
A decrease in TIDA neuronal activity has been clearly implicated in
maintaining the high PRL levels associated with a prolonged suckling
stimulus (4, 5, 6, 7, 8, 9). This study supports the inverse relationship between
TIDA neuronal activity and PRL secretion in the lactating rat.
Furthermore, these data endorse the notion that the endogenous opioid
peptides are an essential component in maintaining elevated PRL levels
by acting on the TIDA neurons. TH activity in the SME was increased
after 12 h of NAL infusion. This occurred when the dams were
constantly exposed to the pups and after a 1-h suckling episode in dams
deprived of their pups for an 11-h period. It can be inferred from
these data, that the TH activity was elevated after the 11-h separation
period and that the suckling stimulus resulted in a decrease in TH
activity within 6075 min after the onset of suckling. Although the
experimental designs were somewhat different, these data are in general
agreement with previous reports that the suckling stimulus acutely
decreases dopamine turnover and TH activity in the median eminence (5, 7).
The prolonged blockade of opioid receptors in the present study also
revealed that opioidergic input affects the expression of the TH gene
in the TIDA neurons. TH mRNA signal levels in the arcuate nucleus were
markedly increased after the 12-h NAL infusion. In fact, it is notable
that the increase in TH gene expression caused by the NAL infusion is
similar to that associated with pup separation (8, 9). The 12-h
duration for the NAL infusion was selected because TH mRNA content in
the arcuate nucleus is not significantly increased until 6 h after
separation and continues to increase between 6 and 24 h after pup
removal (8). The increases in TH gene expression after pup separation
(9) and NAL infusion (this study) seem to be specific to the TIDA
neurons and are not observed in dopaminergic neurons in the medial zona
incerta.
The data are in general agreement with those by Callahan et
al. (38) that a µ-selective, but not
-selective, opioid
receptor antagonist increased DOPA accumulation in the median eminence
of both pup-deprived and pup-suckled dams after a 4- to 5-h separation
period. The differences in timing and mode of antagonist administration
[i.e. 4 h for µ-selective antagonist and 45 min for
-selective antagonist, by Callahan et al. (38), and 12-h
continuous administration of NAL in the present study] make it
difficult to draw conclusions about the specific receptor subtype
involved in regulating TH gene expression. However, given that NAL has
a high affinity for µ-opioid receptors, moderate affinity for
-opioid receptors, and relatively low affinity for
-opioid
receptors (44), it is likely that either µ- and/or
-type receptors
may be involved in the opioidergic effects on TH activity and mRNA
levels in the TIDA neurons in the constantly suckled lactating
model.
The physiological consequences on the pups during the 12-h NAL
infusion were remarkable. The pups of the NAL-treated dams failed to
gain weight during the 12-h infusion period, whereas pups of control
dams gained a significant amount of weight. However, the pups
apparently did receive some milk during the NAL infusion, because
complete separation from dams resulted in pup weight loss. This could
not be explained by disruption of maternal behavior, because the time
control and NAL-treated dams spent with the pups was similar.
Observation of the pups indicated that the pups in the NAL-treated
group were suckling vigorously when the dams were with the nest.
Indeed, opiates disrupt maternal behavior, and NAL can prevent this
disruption (45, 46). Although there is some controversy on the effect
of endogenous opioid peptides on oxytocin secretion, it is unlikely
that milk ejection failure caused the lack of weight gain in the
present study. Hartman et al. (47) reported that NAL
treatment did not alter the suckling-induced oxytocin release in
conscious, normally hydrated rats, as with the dams in the present
study. Reports of an opioid effect on oxytocin neurons indicate that
the opioid action on oxytocinergic neurons is to restrain oxytocin
release and that NAL augments oxytocin secretion (48).
The apparent escape of PRL release from the NAL-induced suppression was
also somewhat striking. Although slightly variable among animals, this
phenomenon seems to be synchronized at 6 h and 10 h after the
initiation of NAL infusion. In a physiological sense, this may reflect
the importance of lactation to sustaining mammalian species and, thus,
the multiple mechanisms to maintain adequate lactation.
It is unclear whether the NAL effects on PRL secretion solely involve
changes in TIDA neuronal activity. There is evidence that decreased
dopaminergic activity may not completely account for opiate-induced PRL
release and that PRL-releasing factor(s) may also be involved (26, 27).
Indeed, one cannot rule out the possibility that the endogenous opioid
peptides could alter nondopaminergic neurons, as well, and that effects
on other factors could also contribute to the NAL suppression of
suckling-induced PRL release. This study also does not identify which
of the major opioidergic neuronal systems contribute to the control of
PRL secretion during lactation. However, proenkephalin expression in
the arcuate nucleus (19) and dynorphin expression in the
paraventricular nucleus (21) are higher in lactating rats than in
diestrous rats.
In conclusion, the endogenous opioid peptides are an integral component
in the suckling-dependent elevation of PRL secretion during lactation.
Moreover, the endogenous opioid peptides reduce TIDA neuronal activity
in response to suckling and contribute to the marked suppression of TH
gene expression during lactation. Without the opioidergic input, normal
lactation seems to be severely compromised. These data support the
notion that the TIDA neurons are an intermediate in the essential
opioidergic enhancement of PRL secretion in response to suckling.
 |
Acknowledgments
|
|---|
We wish to thank the National Hormone and Pituitary Program
(NIDDK, NICHHD, USDA) for the gift of PRL RIA materials.
 |
Footnotes
|
|---|
1 This work was supported by a Kansas University Medical Center
Research Institute grant (to L.A.A.) and NIH Grant HD-24190 (to
J.L.V.). 
Received December 9, 1997.
 |
References
|
|---|
-
Samson WK, Lumpkin MD, McCann SM 1986 Evidence
for a physiological role for oxytocin in the control of prolactin
secretion. Endocrinology 119:554560[Abstract]
-
Murai I, Ben-Jonathan N 1987 Posterior pituitary
lobectomy abolishes the suckling-induced rise in prolactin (PRL):
evidence for a PRL-releasing factor in the posterior pituitary.
Endocrinology 121:205211[Abstract]
-
Samson WK, Bianchi R, Mogg RJ, Rivier J, Vale W, Melin
P 1989 Oxytocin mediates the hypothalamic action of vasoactive
intestinal peptide to stimulate prolactin secretion. Endocrinology 124:812819[Abstract]
-
Ben-Jonathan N, Neill MA, Arbogast LA, Peters LL,
Hoefer MT 1980 Dopamine in hypophysial portal blood: relationship
to circulating prolactin in pregnant and lactating rats. Endocrinology 106:690696[Medline]
-
Selmanoff M, Wise PM 1981 Decreased dopamine
turnover in the median eminence in response to suckling in the
lactating rat. Brain Res 212:101115[CrossRef][Medline]
-
Plotsky PM, Neill JD 1982 The decrease in
hypothalamic dopamine secretion induced by suckling: comparison of
voltammetric and radioisotopic methods of measurement. Endocrinology 110:691696[Abstract]
-
Demarest KT, McKay DW, Riegle GD, Moore KE 1983 Biochemical indices of tuberoinfundibular dopaminergic neuronal
activity during lactation: a lack of response to prolactin.
Neuroendocrinology 36:130137[Medline]
-
Wang H-J, Hoffman GE, Smith MS 1993 Suppressed
tyrosine hydroxylase gene expression in the tuberoinfundibular
dopaminergic system during lactation. Endocrinology 133:16571663[Abstract]
-
Arbogast LA, Voogt JL 1996 The responsiveness of
tuberoinfundibular dopaminergic neurons to prolactin feedback is
diminished between early lactation and midlactation in the rat.
Endocrinology 137:4754[Abstract]
-
Hoffman GE, Le W-W, Abbud R, Lee W-S, Smith MS 1994 Use of Fos-related antigens (FRAs) as markers of neuronal activity: FRA
changes in dopamine neurons during proestrus, pregnancy and lactation.
Brain Res 654:207215[CrossRef][Medline]
-
Selmanoff M, Gregerson KA 1986 Suckling-induced
prolactin release is suppressed by naloxone and stimulated by
ß-endorphin. Neuroendocrinology 42:255259[CrossRef][Medline]
-
Baumann MH, Rabii J 1991 Inhibition of
suckling-induced prolactin release by µ- and
-opioid antagonists.
Brain Res 567:224230[CrossRef][Medline]
-
Kehoe L, Parman R, Janik J, Callahan P 1993 Opiate
receptor subtype involvement in the stimulation of prolactin release by
ß-endorphin in female rats. Neuroendocrinology 57:875883[Medline]
-
Baumann MH, Rabii J 1990 Mu-selective opioid
peptides stimulate prolactin release in lactating rats. J
Neuroendocrinol 2:271284
-
Smith MS 1993 Lactation alters neuropeptide-Y and
proopiomelanocortin gene expression in the arcuate nucleus of the rat.
Endocrinology 133:12581265[Abstract]
-
Mann PE, Rubin BS, Bridges RS 1997 Differential
proopiomelanocortin gene expression in the medial basal hypothalamus of
rats during pregnancy and lactation. Mol Brain Res 46:916[Medline]
-
Fitzsimmons MD, Olschowka JA, Wiegnad SJ, Hoffman
GE 1992 Interaction of opioid peptide-containing terminals with
dopaminergic perikarya in the rat hypothalamus. Brain Res 581:1018[CrossRef][Medline]
-
Horvath TL, Naftolin F, Leranth C 1992 ß-Endorphin innervation of dopamine neurons in the rat hypothalamus:
a light and electron microscopic double immunostaining study.
Endocrinology 131:15471555[Abstract]
-
Ottinger MA, Rosewell KL, Weiland NG, Margaretten KT,
Wise PM 1995 Effect of lactation on hypothalamic proenkephalin
gene expression. J Neuroendocrinol 7:341346[CrossRef][Medline]
-
Merchenthaler I 1993 Induction of enkephalin in
tuberoinfundibular dopaminergic neurons during lactation. Endocrinology 133:26452651[Abstract]
-
Eriksson M, Ceccatelli S, Uvnäs-Moberg K, Iadarola
M, Hökfelt T 1996 Expression of fos-related antigens,
oxytocin, dynorphin and galanin in the paraventricular and supraoptic
nuclei of lactating rats. Neuroendocrinology 63:356367[Medline]
-
Manzanares J, Wagner EJ, Lookingland KJ, Moore KE 1992 Effects of immunoneutralization of dynorphin117 and
dynorphin18 on the activity of central dopaminergic
neurons in the male rat. Brain Res 587:301305[CrossRef][Medline]
-
Voogt JL, Resch G, Turkington S 1989 Arcuate
nucleus and preoptic area involvement in beta-endorphin-induced release
of prolactin in conscious ovariectomized rats. J Neuroendocrinol 1:449453[CrossRef]
-
Rivier C, Vale W, Ling N, Brown M, Guillemin R 1977 Stimulation in vivo of the secretion of prolactin and growth
hormone by ß-endorphin. Endocrinology 100:238241[Abstract]
-
Wiesner JB, Koenig JI, Krulich L, Moss RL 1984 Site
of action for ß-endorphin-induced changes in plasma luteinizing
hormone and prolactin in the ovariectomized rat. Life Sci 34:14631473[CrossRef][Medline]
-
Arita J, Porter JC 1984 Relationship between
dopamine release into hypophysial portal blood and prolactin release
after morphine treatment in rats. Neuroendocrinology 38:6267[CrossRef][Medline]
-
Shin SH, Obonsawin MC, VanVugt DA, Baby N 1988 Morphine can stimulate prolactin release independent of a dopaminergic
mechanism. Can J Physiol Pharmacol 66:13811385[Medline]
-
Ferland L, Fuxe K, Eneroth P, Gustafsson J-A, Skett
P 1977 Effects of methionine-enkephalin on prolactin release
and catecholamine levels and turnover in the median eminence. Eur
J Pharmacol 43:8990[CrossRef][Medline]
-
Arita J, Kimura F 1988 Enkephalin inhibits dopamine
synthesis in vitro in the median emience portion of rat
hypothalamic slices. Endocrinology 123:694699[Abstract]
-
Deyo SN, Swift RM, Miller RJ 1979 Morphine and
endorphins modulate dopamine turnover in rat median eminence. Proc Natl
Acad Sci USA 76:30063009[Abstract/Free Full Text]
-
Gudelsky GA, Porter JC 1979 Morphine- and opioid
peptide-induced inhibition of the release of dopamine from
tuberoinfundibular neurons. Life Sci 25:16971702[CrossRef][Medline]
-
VanLoon GR, Ho D, Kim C 1980 ß-Endorphin-induced
decrease in hypothalamic dopamine turnover. Endocrinology 106:7680[Abstract]
-
Alper RH, Demarest KT, Moore KE 1980 Morphine
differentially alters synthesis and turnover of dopamine in central
neuronal systems. J Neural Transm 48:157165[CrossRef]
-
Reymond MJ, Kaur C, Porter JC 1983 An inhibitory
role for morphine on the release of dopamine into hypophysial portal
blood and on the synthesis of dopamine in tuberoinfundibular neurons.
Brain Res 262:253258[CrossRef][Medline]
-
Manzanares J, Wagner EJ, LaVigne SD, Lookingland KJ,
Moore KE 1992 Sexual differences in kappa opioid receptor-mediated
regulation of tuberoinfundibular dopaminergic neurons.
Neuroendocrinology 55:301307[Medline]
-
Manzanares J, Durham RA, Lookingland KJ, Moore KE 1993
-Opioid receptor-mediated regulation of central
dopaminergic neurons in the rat. Eur J Pharmacol 249:107112[CrossRef][Medline]
-
Sagrillo CA, Voogt JL 1991 Endogenous opioids
mediate the nocturnal prolactin surge in the pregnant rat.
Endocrinology 129:925930[Abstract]
-
Callahan P, Baumann MH, Rabii J 1996 Inhibition of
tuberoinfundibular dopaminergic neural activity during suckling:
involvement of µ and
opiate receptor subtypes. J
Neuroendocrinol 8:771776[CrossRef][Medline]
-
Arbogast LA, Voogt JL 1991 Hyperprolactinemia
increases and hypoprolactinemia decreases tyrosine hydroxylase
messenger ribonucleic acid levels in the arcuate nuclei, but not the
substantia nigra or zona incerta. Endocrinology 128:9971005[Abstract]
-
Bradford MM 1976 A rapid and sensitive method for
the quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal Biochem 72:248254[CrossRef][Medline]
-
Paxinos G, Watson C 1986 The Rat Brain in
Stereotaxic Coordinates. Academic Press, New York
-
Zar JH 1984 Biostatistical Analysis. Prentice-Hall,
ed. 2, Englewood Cliffs, NJ
-
Gerald KB 1990 Common multiple comparison
procedures. Nurse Anesthesia 1:162165[Medline]
-
Minami M, Satoh M 1995 Molecular biology of the
opioid receptors: structures, functions and distributions. Neurosci Res 23:121145[CrossRef][Medline]
-
Bridges RS, Grimm CT 1982 Reversal of morphine
disruption of maternal behavior by concurrent treatment with the opiate
antagonist naloxone. Science 218:166168[Abstract/Free Full Text]
-
Mann PE, Kinsley CH, Bridges RS 1991 Opioid
receptor subtype involvement in maternal behavior in lactating rats.
Neuroendocrinology 53:487492[Medline]
-
Hartman RD, Rosella-Dampman LM, Summy-Long JY 1987 Endogenous opioid peptides inhibit oxytocin release in the lactating
rat after dehydration and urethane. Endocrinology 121:536543[Abstract]
-
Russell JA, Coombes JE, Leng G, Bicknell RJ 1993 Morphine tolerance and inhibition of oxytocin secretion by
-opioids
acting on the rat neurohypophysis. J Physiol 469:365386[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
C. Deachapunya, S. Poonyachoti, and N. Krishnamra
Regulation of electrolyte transport across cultured endometrial epithelial cells by prolactin
J. Endocrinol.,
June 1, 2008;
197(3):
575 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Thongon, L.-i. Nakkrasae, J. Thongbunchoo, N. Krishnamra, and N. Charoenphandhu
Prolactin stimulates transepithelial calcium transport and modulates paracellular permselectivity in Caco-2 monolayer: mediation by PKC and ROCK pathways
Am J Physiol Cell Physiol,
May 1, 2008;
294(5):
C1158 - C1168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jantarajit, N. Thongon, J. Pandaranandaka, J. Teerapornpuntakit, N. Krishnamra, and N. Charoenphandhu
Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by the phosphoinositide 3-kinase pathway
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E372 - E384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev.,
December 1, 2001;
22(6):
724 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. B. Andrews, I. C. Kokay, and D. R. Grattan
Dissociation of Prolactin Secretion from Tuberoinfundibular Dopamine Activity in Late Pregnant Rats
Endocrinology,
June 1, 2001;
142(6):
2719 - 2724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev,
October 1, 2000;
80(4):
1523 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|